News

Published on 27 Dec 2024 on Benzinga

US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About...

Article preview image

U.S. stock futures tumbled on Friday in premarket hours after a mixed Thursday. All four index futures slipped in trade.

While the S&P 500 index is on its way to registering a robust 20% plus return for the second consecutive year in 2024 it ended lower on the second day of the Santa rally after advancing 1.1% on Christmas Eve. Analysts say that the full ‘Santa Claus Rally’ has never been lower.

Read the rest of the article
NASDAQ.VIRX price evolution
NASDAQ.GDYN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday -...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 27 Dec 2024
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.77% By...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.77%

Investing.com 27 Dec 2024
US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About...

U.S. stock futures tumbled on Friday in premarket hours after a mixed Thursday. All four index fu...

Benzinga 27 Dec 2024
Viracta Therapeutics Explores Strategic Options After NAVAL-1 Closure

Viracta Therapeutics ( (VIRX) ) just unveiled an update. Viracta Therapeutics has announced the...

TipRanks · via Yahoo Finance 27 Dec 2024
Castellum, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday...

Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — a...

Benzinga 27 Dec 2024
Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store...

Party City Holdco Inc., the one-stop-shop for all things celebration, is calling it a wrap. The c...

Benzinga 27 Dec 2024
Viracta Therapeutics Inc (VIRX) Reports Q3 2023 Financial Results Amid Clinical Advances

Viracta Therapeutics Inc (NASDAQ:VIRX) announced preliminary clinical data from the NAVAL-1 trial...

GuruFocus.com via Yahoo Finance 9 Nov 2023
WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

WAVE Life Sciences Ltd. (NASDAQ:WVE), a preclinical biopharmaceutical company, has seen a signifi...

GuruFocus.com via Yahoo Finance 23 Aug 2023
Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next...

Viracta Therapeutics Inc (NASDAQ: VIRX) announced that the relapsed or refractory EBV+ peripheral...

Benzinga via Yahoo Finance 28 Jun 2023
Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 28 Sep 2022

Copyright Statfolio @ 2025

Social Accounts